Innate Pharma SA financial data

Symbol
IPHA on Nasdaq, IPHYF on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
117 Avenue De Luminy, Bp 30191, Marseille, France
State of incorporation
France
Fiscal year end
December 31
Latest financial report
Q4 2023 - Apr 4, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 80.5M shares +1.15%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 56M EUR +8.44%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 184M EUR -11.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Interest Expense 640K EUR +122%